Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
IONIS PHARMACEUTICALS INC (IONS)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 8-K | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 424.8 | 2,347.0 | 276.5 | 315.0 | 521.9 | 542.5 | 869.2 | 633.0 |
| Short-term investments | 1,960.6 | | 1,710.4 | 1,666.7 | 1,499.9 | 1,509.9 | 1,245.8 | 1,354.1 |
| Inventories | 25.5 | | 22.0 | 20.6 | 19.8 | 24.0 | 24.8 | 22.9 |
| Other current assets | 205.8 | 182.0 | 193.8 | 149.8 | 149.5 | 176.7 | 205.3 | 145.7 |
| Total current assets | 2,616.8 | 2,529.0 | 2,202.7 | 2,152.1 | 2,191.1 | 2,253.1 | 2,345.0 | 2,155.7 |
| Property, plant, and equipment, net | 91.6 | 85.0 | 74.3 | 180.8 | 177.0 | 177.7 | 178.1 | 180.1 |
| Intangibles | | | | 29.6 | 29.1 | 29.3 | | 30.0 |
| Long-term investments | 457.3 | | 509.8 | 579.4 | 497.6 | | 635.1 | |
| Other fixed assets | 86.0 | 78.0 | 75.3 | 59.4 | 58.9 | 58.9 | 70.6 | 49.0 |
| Total assets | 2,971.1 | 2,885.0 | 2,533.9 | 2,422.0 | 2,456.1 | 2,519.1 | 2,611.7 | 2,414.9 |
| |
| Accounts payable | 24.0 | | 17.9 | 20.5 | 10.4 | 16.1 | 11.9 | 8.4 |
| Accrued expenses | 104.7 | | 140.1 | 128.0 | 134.3 | 99.3 | 88.6 | 75.7 |
| Current portion of long-term debt | 0.0 | 0.0 | 0.0 | 5.0 | 4.7 | 4.2 | 0.0 | 65.0 |
| Current portion of long-term debt | | | | 5.0 | 4.7 | 4.2 | | 3.1 |
| Other current liabilities | 159.2 | 167.0 | 153.5 | 129.9 | 118.4 | 108.9 | 140.1 | 130.7 |
| Total current liabilities | 288.0 | 167.0 | 311.6 | 283.5 | 267.8 | 228.5 | 240.6 | 279.8 |
| Long-term debt | | 16.0 | 8.8 | 84.1 | 84.3 | 85.2 | 59.7 | 81.6 |
| Other liabilities | 2,254.9 | 273.0 | 1,640.6 | 1,460.1 | 1,479.3 | 1,495.9 | 1,539.7 | 1,523.0 |
| Total liabilities | 2,542.8 | 456.0 | 1,961.0 | 1,827.6 | 1,831.4 | 1,809.5 | 1,840.0 | 1,884.4 |
| |
| Shareholders' equity [+] | 428.3 | 2,429.0 | 572.9 | 594.4 | 624.7 | 709.6 | 771.7 | 530.5 |
| Paid-in capital | 2,118.3 | | 2,059.9 | 2,034.6 | 2,008.8 | 1,983.1 | 1,964.2 | 1,942.3 |
| Retained earnings | -1,639.2 | | -1,429.6 | -1,377.2 | -1,330.2 | -1,225.1 | -1,159.9 | -1,384.5 |
| Tangible shareholders' equity | 428.3 | 2,429.0 | 572.9 | 564.8 | 595.7 | 680.3 | 771.7 | 500.5 |
|